Pharmacovigilance in Vaccines and Biologics

Vaccines and biologics present unique pharmacovigilance challenges due to their complex structures, immune-mediated mechanisms, and wide-scale population use. Post-marketing surveillance for these products is vital to detect rare or long-term adverse events that may not be captured during pre-approval studies. Pharmacovigilance efforts must focus on passive and active surveillance systems, vaccine safety datalink (VSD) analyses, and signal detection tools tailored to biological therapies. Regulatory agencies such as the FDA and EMA mandate rigorous safety evaluations, periodic safety update reports (PSURs), and risk management plans (RMPs) specifically adapted to biologics. Transparency in communicating safety data and fostering public trust is also essential, especially in the context of vaccine hesitancy. The evolving landscape of biosimilars further demands refined pharmacovigilance strategies to assess immunogenicity and batch consistency. This session explores the integration of real-world data, post-authorization safety studies (PASS), and collaborative global safety initiatives that ensure comprehensive pharmacovigilance for vaccines and biologics.

    Related Conference of Pharmacovigilance in Vaccines and Biologics

    December 01-02, 2025

    13th International Conference on Clinical Trials

    Vancouver, Canada
    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Pharmacovigilance in Vaccines and Biologics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in